Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

VERTEX STOPS TEST OF RARE DISEASE DRUG, DIMMING PIPELINE PROSPECTS

Vertex Pharmaceuticals is halting work on an experimental drug for a rare protein deficiency after safety problems were reported in...

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

SANOFI, PFIZER & BRISTOL DRUGS AMONG THE 12 APPROVALS TO LOOK OUT FOR IN Q4

The end of the year should see a flurry of new products reaching the market to break new commercial ground or shake up their respective...

 
 
 
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies

ROCHE ENLISTS DYNO TO BRING AI TO NEXT-GENERATION LIVER, CNS GENE THERAPIES

Roche made a splash with its acquisition of Spark Therapeutics, whose Luxturna, a gene therapy for an inherited form of vision loss,...

Codiak Bio's IPO Brings In $82M as Exosome Clinical Trials Begin

CODIAK BIO'S IPO BRINGS IN $82M AS EXOSOME CLINICAL TRIALS BEGIN

Codiak BioSciences now has $82.5 million to fund clinical tests of a new class of medicines based on exosomes, tiny bubbles formed...

 
 
 
Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

DESPITE PHASE 2 FAILURE, GOSSAMER BIO SEES A PATH FOR DRUG IN ASTHMA

Gossamer Bio's lead drug, an experimental treatment for asthma and allergies, has failed in two mid-stage clinical trials but the biotech...

SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D

SQZ BIOTECH LINES UP AN IPO ON THE NYSE TO FUND CELL THERAPY R&D

SQZ Biotechnologies, which already has an alliance with Roche focused on developing new cancer cell therapies, is now looking to sell...

 
 
 
“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

“OPIOID STACKING” CONCERNS LEAD FDA TO REJECT AVENUE THERAPEUTICS DRUG

An opioid that Avenue Therapeutics reformulated for treating post-surgical pain in hospital settings has been rejected by the FDA due...

 
 
 
Bio Roundup: CRISPR Kudos, Bristol Myers's Buy, RNAi Alliance & More

BIO ROUNDUP: CRISPR KUDOS, BRISTOL MYERS'S BUY, RNAI ALLIANCE & MORE

It's October: a time of days growing shorter, leaves changing color, and phone calls in the wee hours that rouse scientists from slumber...

Biogen's AdComm Meeting Will Test FDA's “Substantial Evidence” Flexibility

BIOGEN'S ADCOMM MEETING WILL TEST FDA'S “SUBSTANTIAL EVIDENCE” FLEXIBILITY

A US Food and Drug Administration advisory committee meeting on Biogen, Inc.'s Alzheimer's drug aducanumab will offer some insight...

 
 
 
 
 
 
 
 
 
Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries

GENFIT RESTRUCTURING CUTS STAFF BY 40%, CREATES TWO NEW SUBSIDIARIES

Genfit is halting all work on its lead drug in the fatty liver disorder nonalcoholic steatohepatitis and implementing a corporate restructuring...

Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B

BRISTOL MYERS TO BUY MYOKARDIA, FDA-READY HEART DISEASE DRUG FOR $13.1B

Bristol Myers Squibb is bolstering its cardiovascular drug lineup with a $13.1 billion deal to acquire MyoKardia, a company whose experimental...

 
 
 
Bristol Myers's Hirawat on Pipeline Progress, Clinical Trial Diversity

BRISTOL MYERS'S HIRAWAT ON PIPELINE PROGRESS, CLINICAL TRIAL DIVERSITY

As the one-year anniversary of Bristol-Myers Squibb Company's $74bn acquisition of Celgene Corporation approaches, Scrip spoke with...

Bio Roundup: MESO's Miss, Pfizer's Cancer Bet, Vaccine Promise & More

BIO ROUNDUP: MESO'S MISS, PFIZER'S CANCER BET, VACCINE PROMISE & MORE

Amid the bombast of Tuesday's presidential debate, viewers caught some discussion about the response to the coronavirus pandemic and...

 
 
 
FDA Lifts Solid Bio Clinical Hold, Duchenne Study Cleared to Resume

FDA LIFTS SOLID BIO CLINICAL HOLD, DUCHENNE STUDY CLEARED TO RESUME

Solid Biosciences has answered the FDA's outstanding questions about its Duchenne muscular gene therapy, clearing a clinical trial...

Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries

GENFIT RESTRUCTURING CUTS STAFF BY 40%, CREATES TWO NEW SUBSIDIARIES

Genfit is halting all work on its lead drug in the fatty liver disorder nonalcoholic steatohepatitis and implementing a corporate restructuring...

 
 
 



World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Four months in, Baker lab hits the ground running and won't be stopping...

Four months in, Baker lab hits the ground running and won't be stopping anytime soon

Post doctorate Harim Tavares from the Baker lab works in “the hood,” which is a space used to prevent researchers and other outside factors from contaminating cells. By Lauren... Read more ...

IAmScience Karl Kerns

IAmScience Karl Kerns

By Becca Wolf | Bond LSC It's all about the journey and Karl Kerns has been places. Originally from a small town in southwestern Iowa, Kerns did his undergrad years at Iowa... Read more ...

IAmScience Alana Rodney

IAmScience Alana Rodney

By Lauren Hines | Bond LSC Research assistant Alana Rodney walked into her high school science class a few years ago expecting to fill another credit. However, it was there... Read more ...

Regulators Classify Gene-Edited Rice Varieties with Disease Resistance as...

Regulators Classify Gene-Edited Rice Varieties with Disease Resistance as Equivalent to Conventional Varieties

Crops resist bacterial leaf blight; ruling clears path to provide smallholder farmers with a safe, affordable option for preventing destructive disease A farmer works on paddy... Read more ...

Finding a Link between Xenoestrogens and Autism

Finding a Link between Xenoestrogens and Autism

California mice | photo by Roger Meissen, Bond LSC By Becca Wolf | Bond LSC It's hard to see a family member treated differently because of a behavior disorder, but those with... Read more ...

IAmScience Norma Castro-Guerrero

IAmScience Norma Castro-Guerrero

By Becca Wolf | Bond LSC If you like your work, you won't ever work a day in your life. That's the case for Norma Castro-Guerrero, a research scientist in David Mendoza's lab... Read more ...

Plant vs. Pathogen

Plant vs. Pathogen

Research scientist Jianbin Su studies the immune system in lettuce on the third floor of the Bond Life Science Center. By Lauren Hines | Bond LSC Scientist Jianbin Su's... Read more ...

Influenza: How it Transmits from Birds to Pigs

Influenza: How it Transmits from Birds to Pigs

Henry Wan | Photo by Roger Meissen, Bond LSC By Becca Wolf Geese will soon fill the skies as they migrate south in V-formation as the weather gets colder and the leaves start... Read more ...

Beyond the Vaccine

Beyond the Vaccine

Lucas Woods from the Weisman lab watches lung cancer cells and oral epithelial cells grow. | photo by Lauren Hines, Bond LSC By Lauren Hines | Bond LSC Vaccine development... Read more ...

Egyptian Genome Added to Growing List of Population-Specific Reference Genomes

Egyptian Genome Added to Growing List of Population-Specific Reference Genomes

We're excited to report that another team has used PacBio long-read sequencing to produce a population-specific reference genome - this time an Egyptian genome that should... Read more ...